Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:00700306n
Noun Named Entity
EL
No term available
EN
The United States Food and Drug Administration's Investigational New Drug program is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines before a marketing application for the drug has been approved. Wikipedia
Relations
Sources
PART OF
κλινική έρευνα
PARTIALLY COINCIDENT WITH
EN
trial master file

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License